Clonotypic B cells in WM are characterized as CD20+CD138−IgM+IgD+ and CD20+CD138+ cells
. | . | . | . | Clonotypic B cells with different clonal isotype expression, % . | . | |
---|---|---|---|---|---|---|
Phenotypic marker and patient . | Source . | No. cells analyzed . | Clonal frequencies, % . | μ+δ+ . | μ+δ− . | |
CD20+CD138− | ||||||
WM1-06.1* | BM | 48 | 96 | NA | NA | |
WM1-06.2* | BM | 96 | 58 | NA | NA | |
WM1-09 | BM | 96 | 61 | 30 | 70 | |
WM1-14 | BM | 96 | 39 | NA | NA | |
WM1-11 | BM | 96 | 57 | NA | NA | |
WM1-11 | Blood | 144 | 2 | NA | NA | |
WM1-13 | BM | 72 | 65 | 35 | 65 | |
WM1-13 | Blood | 72 | 69 | 39 | 61 | |
IgM+IgD+ | ||||||
WM1-08 | BM | 72 | 77 | 64 | 36 | |
WM1-11 | BM | 72 | 86 | NA | NA | |
WM1-13 | BM | 72 | 89 | 31 | 69 | |
WM1-13 | Blood | 72 | 81 | 42 | 58 | |
CD20+CD138+ | ||||||
WM1-09 | BM | 48 | 92 | 4 | 96 |
. | . | . | . | Clonotypic B cells with different clonal isotype expression, % . | . | |
---|---|---|---|---|---|---|
Phenotypic marker and patient . | Source . | No. cells analyzed . | Clonal frequencies, % . | μ+δ+ . | μ+δ− . | |
CD20+CD138− | ||||||
WM1-06.1* | BM | 48 | 96 | NA | NA | |
WM1-06.2* | BM | 96 | 58 | NA | NA | |
WM1-09 | BM | 96 | 61 | 30 | 70 | |
WM1-14 | BM | 96 | 39 | NA | NA | |
WM1-11 | BM | 96 | 57 | NA | NA | |
WM1-11 | Blood | 144 | 2 | NA | NA | |
WM1-13 | BM | 72 | 65 | 35 | 65 | |
WM1-13 | Blood | 72 | 69 | 39 | 61 | |
IgM+IgD+ | ||||||
WM1-08 | BM | 72 | 77 | 64 | 36 | |
WM1-11 | BM | 72 | 86 | NA | NA | |
WM1-13 | BM | 72 | 89 | 31 | 69 | |
WM1-13 | Blood | 72 | 81 | 42 | 58 | |
CD20+CD138+ | ||||||
WM1-09 | BM | 48 | 92 | 4 | 96 |
One hundred percent of clonotypic B cells expressed clonal μ transcript. Clonal frequency was calculated as the percentage of sorted cells that expressed clonal μ transcript over the total number of cells that showed positive PCR results to β2-microglobulin or universal immunoglobulin control.
NA indicates not applicable.
BM samples from WM1-06 were collected 9 months apart.